3 completed, 1 unknown. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow racotumomab: new trials by email Literature Review of racotumomab trials Research Report on racotumomab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Racotumomab in Patients With High-risk Neuroblastoma Racotumomab - Neuroblastoma | Phase 2 | Completed | Laboratorio Elea Phoenix S.A. | 39 | 2016-11-01 | 2023-09-11 |
| Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides racotumomab - Neuroblastoma, Ewing's Sarcoma | Phase 1 | Completed | Laboratorio Elea Phoenix S.A. | 15 | 2011-02-01 | 2015-07-29 |
| Immunotherapy With Racotumomab in Advanced Lung Cancer Racotumomab, Best Support Treatment - NSCLC, Lung Cancer, Non-small Cell | Phase 3 | Unknown | Recombio SL | 1082 | 2010-09-01 | 2016-07-29 |
| Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients racotumomab, Best support treatment - Advanced Non-small Cell Lung Cancer | Phase 2 | Completed | Laboratorio Elea Phoenix S.A. | 7 | 2009-09-01 | 2014-07-10 |
Neuroblastoma (2) · Small Cell Lung Carcinoma (2) · Carcinoma, Non-Small-Cell Lung (1) · Glioma (1) · Retinoblastoma (1) · Sarcoma, Ewing (1) · Wilms Tumor (1)
Laboratorio Elea Phoenix S.A. (3) · Recombio SL (1)
Argentina (4) · Brazil (1) · Cuba (1) · Indonesia (1) · Philippines (1) · Singapore (1) · Thailand (1)
Walter Cacciavillano, MD (2) · Gabriela Cinat, MD (1) · Guillermo Chantada, MD (1) · Roberto Gomez, M.D. (1)